Regulation - Asia-Pacific, ipragliflozin

Filter

Current filters:

Asia-Pacificipragliflozin

Popular Filters

Astellas files for Japanese approval of ipragliflozin for types 2 diabetes

14-03-2013

Japanese drug major Astellas Pharma (TYO: 4503) has submitted a market authorization application for…

Asia-PacificAstellas PharmaDiabetesipragliflozinPharmaceuticalRegulation

Back to top